Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension

Overview of attention for article published in Integrated Blood Pressure Control, January 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 tweeter

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Comparative effectiveness of oral prostacyclin pathway drugs on hospitalization in patients with pulmonary hypertension in the United States: a retrospective database analysis

Article in Pulmonary Circulation (October 2020)

Transitions between infused and oral prostacyclin pathway agents in pulmonary arterial hypertension: key considerations

Article in Pulmonary Circulation (June 2020)

Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension

Article in Pulmonary Circulation (January 2020)